For instance, in several murine stroke models, AnxA1 administration mediated protective effects via FPR2 after cerebral ischemia/reperfusion (I/R) injury [48] or more recently, after spontaneous intracerebral hemorrhage [49], limiting further cerebral microvascular dysfunction and tissue damage. The gene discussed is ANXA1; the disease is brain ischemia.